&imwidth=600&imheight=450&format=webp&quality=medium)
The Trump administration is expected to announce a potential link between pregnant women's use of Tylenol (Paracetamol) and an increased risk of autism in children today.
The Donald Trump administration, on Monday (Sep 22), is expected to announce the alarming side effects of one of the most commonly used drugs in the world - Tylenol, known as Paracetamol or PCM outside the United States. According to reports, the use of the medicine by pregnant women may be linked to a risk of autism in children. The US government is also expected to unveil information on a “miracle drug” that could treat autism.
Citing people familiar with the plan, reports suggest that federal health agencies will caution against the use of Tylenol — known internationally as paracetamol — during early pregnancy, citing studies that suggest a potential link to autism spectrum disorder in children. While acetaminophen, the salt used in paracetamol, has long been considered safe for pregnant women, the announcement signals a dramatic shift in tone from Washington.
The move comes after months of internal debate and a growing push from Health Secretary Robert F. Kennedy Jr., who has made autism a central focus of the administration’s “Make America Healthy Again” agenda.
Speaking at a memorial service for MAGA activist Charlie Kirk on Sunday, President Donald Trump previewed the announcement in typically bold terms. Tomorrow we’re going to have one of the biggest announcement(s) … medically, I think, in the history of our country,” he said. “I think you’re going to find it to be amazing. I think we found an answer to autism.”
That claim will face immediate scrutiny. Major medical organisations, including the American College of Obstetricians and Gynaecologists, have repeatedly stated there is no clear evidence linking acetaminophen to autism or developmental problems, reports the Washington Post. A large Swedish study of more than two million children published last year reached the same conclusion. Tylenol’s manufacturer, Kenvue Inc., has already pushed back, insisting that “independent, sound science clearly shows that taking acetaminophen does not cause autism.”